Wistuba II - Search Results

1

Molecular changes in second primary lung and breast cancers after therapy for Hodgkin's disease.

Behrens C, Travis LB, Wistuba II, Davis S, Maitra A, Clarke EA, Lynch CF, Glimelius B, Wiklund T, Tarone R, Gazdar AF. Behrens C, et al. Among authors: wistuba ii. Cancer Epidemiol Biomarkers Prev. 2000 Oct;9(10):1027-35. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 11045784

2

Deletions of chromosome 3p are frequent and early events in the pathogenesis of uterine cervical carcinoma.

Wistuba II, Montellano FD, Milchgrub S, Virmani AK, Behrens C, Chen H, Ahmadian M, Nowak JA, Muller C, Minna JD, Gazdar AF. Wistuba II, et al. Cancer Res. 1997 Aug 1;57(15):3154-8. Cancer Res. 1997. PMID: 9242443

3

Comparison of molecular changes in lung cancers in HIV-positive and HIV-indeterminate subjects.

Wistuba II, Behrens C, Milchgrub S, Virmani AK, Jagirdar J, Thomas B, Ioachim HL, Litzky LA, Brambilla EM, Minna JD, Gazdar AF. Wistuba II, et al. JAMA. 1998 May 20;279(19):1554-9. doi: 10.1001/jama.279.19.1554. JAMA. 1998. PMID: 9605900

4

Comparison of features of human breast cancer cell lines and their corresponding tumors.

Wistuba II, Behrens C, Milchgrub S, Syed S, Ahmadian M, Virmani AK, Kurvari V, Cunningham TH, Ashfaq R, Minna JD, Gazdar AF. Wistuba II, et al. Clin Cancer Res. 1998 Dec;4(12):2931-8. Clin Cancer Res. 1998. PMID: 9865903

5

Deletions of chromosome 4 at multiple sites are frequent in malignant mesothelioma and small cell lung carcinoma.

Shivapurkar N, Virmani AK, Wistuba II, Milchgrub S, Mackay B, Minna JD, Gazdar AF. Shivapurkar N, et al. Among authors: wistuba ii. Clin Cancer Res. 1999 Jan;5(1):17-23. Clin Cancer Res. 1999. PMID: 9918198

6

Gallbladder adenomas have molecular abnormalities different from those present in gallbladder carcinomas.

Wistuba II, Miquel JF, Gazdar AF, Albores-Saavedra J. Wistuba II, et al. Hum Pathol. 1999 Jan;30(1):21-5. doi: 10.1016/s0046-8177(99)90295-2. Hum Pathol. 1999. PMID: 9923922

7

Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma.

Wistuba II, Behrens C, Milchgrub S, Bryant D, Hung J, Minna JD, Gazdar AF. Wistuba II, et al. Oncogene. 1999 Jan 21;18(3):643-50. doi: 10.1038/sj.onc.1202349. Oncogene. 1999. PMID: 9989814

8

Genetic changes in the spectrum of neuroendocrine lung tumors.

Onuki N, Wistuba II, Travis WD, Virmani AK, Yashima K, Brambilla E, Hasleton P, Gazdar AF. Onuki N, et al. Among authors: wistuba ii. Cancer. 1999 Feb 1;85(3):600-7. doi: 10.1002/(sici)1097-0142(19990201)85:3<600::aid-cncr10>3.0.co;2-w. Cancer. 1999. PMID: 10091733

9

Loss of heterozygosity at 3p in benign lesions preceding invasive breast cancer.

Euhus DM, Maitra A, Wistuba II, Alberts A, Albores-Saavedra J, Gazdar AF. Euhus DM, et al. Among authors: wistuba ii. J Surg Res. 1999 May 1;83(1):13-8. doi: 10.1006/jsre.1998.5549. J Surg Res. 1999. PMID: 10210636

10

Allelic losses at chromosome 8p21-23 are early and frequent events in the pathogenesis of lung cancer.

Wistuba II, Behrens C, Virmani AK, Milchgrub S, Syed S, Lam S, Mackay B, Minna JD, Gazdar AF. Wistuba II, et al. Cancer Res. 1999 Apr 15;59(8):1973-9. Cancer Res. 1999. PMID: 10213509

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

634 results

Search Page

Filters